Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury

Anuradha Krishnan(WinnMed), Gregory J. Gores(Mayo Clinic in Arizona)
Scientific Reports
January 25, 2024
Cited by 7


Related Papers

Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.4k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
Cholangiocarcinoma
|Nature Reviews Disease Primers|2021|830